We conclude that atrial natriuretic peptide can induce a gradual decrease in blood pressure, sometimes followed by symptomatic hypotension, which occurs suddenly. This phenomenon depends on the duration of the infusion as well as the dose. Moreover, the dose effect is enhanced during low sodium intake. This warrants careful observation of patients with essential hypertension who are given infusions of atrial natriuretic peptide over longer periods. The effect ofdesmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure CHRISTOPHER J MATHIAS, PAUL FOSBRAEY, DAVID F DA COSTA, ANDREW THORNLEY, ROGER BANNISTER Abstract Day and night urine volume, morning and evening body weight, and supine and sitting blood pressure were measured in five patients with chronic autonomic failure who were not receiving treatment with drugs. AU had nocturnal polyuria, overnight weight loss, and a pronounced postural fall in blood pressure, with lowest levels in the morning. Desmopressin (24 ,ug given intramuscularly at 8 pm) reduced nocturnal polyuria, diminished overnight weight loss, raised supine blood pressure, and reduced the postural fail, especially in the morning, when patients were often at their worst.
Introduction
Patients with autonomic failure often find that their symptoms of postural hypotension are worse in the morning. Their blood pressure is often lowest at this time' and this may be related to nocturnal polyuria, which probably reduces the volume of extracellular fluid. To investigate this we studied patients before and after reversal of nocturnal polyuria with an antidiuretic agent, desmopressin.
Patients and methods
Six patients with progressive autonomic failure (four men and two women, aged between 55 and 68) were studied; two also had multiple system atrophy.2 All had severe sympathetic failure and symptomatic postural hypotension. Drugs (fludrocortisone acetate and ephedrine) had -been withdrawn three days previously. Their intake of fluid -and food was unrestricted, and they maintained their normal level of mobility. Urine was collected over periods of 12 hours (9 am to 9 pm and 9 pm to 9 am), and volume, osmolality, and excretion ofsodium and potassium were measured. Patients were weighed at 9 am and 9 pm. Blood pressure (mercury sphygmomanometer) and heart rate (radial pulse) were measured after the patients had been supine for at least 10 minutes and after they had been sitting on the edge of the bed for two minutes. Standing blood pressure was not recorded because some found it difficult to stand, particularly -in the morning. Measurements were taken before meals to avoid postcibal hypotension.3 On the third day haemoglobin concentration, packed cel volume, blood urea, plasma sodium and potassium concentrations, and plasma osmolality were measured. After three control days the observations were repeated, with the addition of 2 ig desmopressin given intramuscularly at 8 pm on the first night, followed by 4 ,ug for two further nights. Blood measurements were repeated after three days' treatment with desmopressin. Patients then either restarted their previous treatment or entered a pilot study to determine a beneficial therapeutic dose of intranasal desmopressin. Five patients who completed the study are analysed here as a group and one:patient is discussed separately as she developed hyponatraemia. Paired and unpaired t tests were used for statistical analysis. Results are expressed as means (SEM).
Results

CONTROL PERIOD
All patients had nocturnal polyuria, with an overnight excess of 169 (79) ml (table I) . Overnight weight loss was 0-74 (0-07) kg (p<001). Nocturnal urinary sodium concentration was greater (p<005) and urinary osmolality was lower than during the day. Supine blood pressure was lowest in the morning and rose during the day (table II) . The postural fall in blood pressure on sitting was similar in the morning and evening, but symptoms were worse in the morning, probably because supine blood pressure was lower.
DESMOPRESSIN PERIOD
After treatment with desmopressin there was a pronounced reduction in nocturnal polyuria (p<0-01) (see table I) and overnight weight loss was reduced. Body weight rose by 1-35 (006) kg (p<0-01) over three days. Supine blood pressure was higher in the morning (see table II), when the postural fall was maximally reduced (p<005). Sitting blood pressure improved during the day. Overnight urinary osmolality " higher (p<0 05) after desmopressin, but sodium excretion remained unchanged. Daytime urinary sodium excretion and osmolality both increased (both p<0 05).
Potassium excretion was unchanged. After treatment with desmopressin there was a small fall in all plasma measurements. Haemoglobin concentration fell from 123 (7) to 120 (11) g/l, packed cell volume from 0 37 (0 2) to 0 35 (0-03), sodium concentration from 141 (0-2) to 136 (2-0) mmol(mEq)/l, potassium concentration from 4-2 ([-0) to 3-9 (0-1) mmol(mEq)/I, urea concentration from 7-2 ([-0) to 6-4 (1-0) mmol/l (43-2 (6-0) to 38-4 (6 0) mg/100 ml), and osmolality from 293 (5) to 276 (3) mmol(mosmol)/kg. Only the fall in osmolality was significant (p<0 05).
The five patients who completed the study telt considerably better when receiving treatment with desmopressin. They were more comfortable at night because nocturia was either reduced or abolished and had fewer postural symptoms during the -day, especially in the morning. None complained of untoward side effects. In one patient treatment with desmopressin improved blood pressure, but she passed no urine on the second night and 500 ml during the next day. She complained of headache, restlessness, and nausea, which suggested water intoxication. Fluid intake had not changed but her weight rose from 48-4 to 50 6 kg. Her plasma sodium concentration fell to 123 mmol(mEq)/l, and the plasma was hypotonic at 250 mmol(mosmol)/kg. Treatment with desmopressin was stopped and fluid restriction was enforced, with the symptoms abating and biochemical values returning to normal after two days.
Discussion
In our patients recumbency caused nocturnal polyuria and an overnight weight loss, which was greater than in similarly aged normal subjects.4 This probably reduced extracellular fluid volume and contracted the intravascular or interstitial compartment, or both, which could have lowered blood pressure in patients who were likely to be sensitive even to small changes because of impaired cardiovascular reflexes. This may account for their low waking blood pressure, which is the opposite of what normally occurs. ' To determine the relation between overnight fluid loss and blood pressure we used the vasopressin analogue desmopressin, which has considerably greater antidiuretic activity but minimal pressor activity when compared with vasopressin (antidiuretic to pressor ratio of 2000-3000:1).6 Desmopressin was an effective antidiuretic, as there was a gain in weight ofover 1-5 kg, but there were no signs of fluid overload, suggesting that these patients have chronic fluid depletion. This supports the observation that patients with autonomic failure have an impaired ability to conserve salt and water as they lose weight and their blood pressure falls when their intake of salt is restricted; there is, however, no firm evidence of a mineralocorticoid deficiency, and their renal responses are only partially rectified by fludrocortisone. 7 The mechanisms accounting for diuresis and natriuresis induced by recumbency may include resistance to mineralocorticoids, inappropriate secretion of vasopressin,8 increased renal perfusion from a rise in blood pressure, and release of atrial natriuretic peptides.9 Whatever the reasons, our patients' nocturnal polyuria was reduced by modest doses of desmopressin and their blood pressure improved. Desmopressin did not, however, reduce the overnight secretion of sodium but increased it, suggesting that combination with fludrocortisone or salt supplementation, or both, may be needed. It is unlikely that desmopressin has direct pressor effects in patients with supersensitivity to vasopressor drugs'"0 as the reverse, hypotension,. has been reported in patients given desmopressin intravenously." 2 The beneficial results that we observed suggest that there may be a therapeutic role for long term tiatment with desmopressin, as indicated by preliminary studies with intranasal desmopressin. Patients should be monitored carefullly, however, especially in the early stages, as exaggerated sensitivity may cause oliguria and hyponatraemia.
